Advanced search
Publication Cover
Journal of Drug Targeting Volume 26, 2018 - Issue 4
Submit an article Journal homepage
419
Views
36
CrossRef citations to date
0
Altmetric
Original Article

A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice

Atefeh ArabBiotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; ;Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; View further author information
,
Javad BehravanBiotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; View further author information
,
Atefeh RazazanDepartment of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; View further author information
,
Zahra GholizadehImmunogenetic and Cell Culture Department, Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; View further author information
,
Amin Reza NikpoorDepartment of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; View further author information
,
Nastaran BaratiBiotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; ;Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; View further author information
,
Fatemeh MosaffaBiotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; View further author information
,
Ali BadieeNanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; ;Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IranView further author information
&
Mahmoud Reza JaafariNanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; ;Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IranCorrespondence[email protected]
View further author information
 show all
Pages 365-372 | Received 10 Jul 2017, Accepted 30 Sep 2017, Published online: 18 Oct 2017

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Maryam Abbaspour & Vajihe Akbari. (2022) Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence. Expert Review of Vaccines 21:3, pages 337-353.
Read now
Patrick M Dillon, Christiana M Brenin & Craig L Slingluff$suffix/text()$suffix/text(). (2020) Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer: Targets and Therapy 12, pages 69-75.
Read now
Anabel Sorolla, Maria Alba Sorolla, Edina Wang & Valentín Ceña. (2020) Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment. Expert Opinion on Drug Delivery 17:11, pages 1597-1613.
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now

Articles from other publishers (32)

Fatemeh Zahedipour, Parvin Zamani, Mohammad Mashreghi, Mojgan Astaneh, Mojtaba Sankian, Atefeh Amiri, Khadijeh Jamialahmadi & Mahmoud Reza Jaafari. (2023) Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma. Cancer Nanotechnology 14:1.
Crossref
Min Yao, Xiyu Liu, Zhangbo Qian, Dianfa Fan, Xinjun Sun, Liping Zhong & Pan Wu. (2023) Research progress of nanovaccine in anti-tumor immunotherapy. Frontiers in Oncology 13.
Crossref
Mojgan Ghaedi, Forough Golsaz-Shirazi, Tannaz Bahadori, Jalal Khoshnoodi, Sahar Mortezagholi, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri & Fazel Shokri. (2022) Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model. Journal of Cancer Research and Clinical Oncology 149:6, pages 2437-2450.
Crossref
Michael H. Zhang, Brianna L. Scotland, Yun Jiao, Emily M. Slaby, Nhu Truong, Andrea L. Cottingham, Georgina Stephanie, Gregory L. Szeto & Ryan M. Pearson. (2023) Lipid–Polymer Hybrid Nanoparticles Utilize B Cells and Dendritic Cells to Elicit Distinct Antigen-Specific CD4 + and CD8 + T Cell Responses . ACS Applied Bio Materials.
Crossref
Arun Kumar Singh, Rishabha Malviya, Bhupendra Prajapati, Sudarshan Singh & Priyanshi Goyal. (2023) Utilization of Stimuli-Responsive Biomaterials in the Formulation of Cancer Vaccines. Journal of Functional Biomaterials 14:5, pages 247.
Crossref
Mohammad Zaki Ahmad, Javed Ahmad, Ahmad Umar, Basel A. Abdel-Wahab, Ahmed A. Lahiq, Zufesha NoorulHuda Khan, Kalyani Pathak, Md Rizwanullah, Musarrat Hussain Warsi, Riya Saikia, Manash Pratim Pathak & Sheheryar Munir. (2023) Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer. Science of Advanced Materials 15:3, pages 285-318.
Crossref
Hitomi Irie, Koji Morita, Miyu Matsuda, Makoto Koizumi & Shinichi Mochizuki. (2023) Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2K b and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA . Bioconjugate Chemistry 34:2, pages 433-442.
Crossref
Zaynab Fatfat, Mia Karam, Batoul Maatouk, Duaa Fahs & Hala Gali-Muhtasib. 2023. Advanced and Modern Approaches for Drug Delivery. Advanced and Modern Approaches for Drug Delivery 159 197 .
Mohsen Akbarian & Shu-Hui Chen. (2022) Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. Pharmaceutics 14:11, pages 2533.
Crossref
Fatemeh Davodabadi, Mohammad Sarhadi, Javad Arabpour, Saman Sargazi, Abbas Rahdar & Ana M. Díez-Pascual. (2022) Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. Journal of Controlled Release 349, pages 844-875.
Crossref
Noraini Abd-Aziz & Chit Laa Poh. (2022) Development of Peptide-Based Vaccines for Cancer. Journal of Oncology 2022, pages 1-17.
Crossref
Alba Navarro-Ocón, Jose L. Blaya-Cánovas, Araceli López-Tejada, Isabel Blancas, Rosario M. Sánchez-Martín, María J. Garrido, Carmen Griñán-Lisón, Jesús Calahorra, Francisca E. Cara, Francisco Ruiz-Cabello, Juan A. Marchal, Natalia Aptsiauri & Sergio Granados-Principal. (2022) Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics 14:3, pages 505.
Crossref
Harishini Rajaratinam, Noor Fatmawati Mokhtar, Nurul Asma-Abdullah & Wan Ezumi Mohd Fuad. (2022) Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives. Biomolecules 12:2, pages 310.
Crossref
Ruiqing He, Jie Zang, Yuge Zhao, Haiqing Dong & Yongyong Li. (2022) Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines. ACS Biomaterials Science & Engineering 8:2, pages 406-423.
Crossref
Nima Behravan, Fatemeh Zahedipour, Mahmoud Reza Jaafari, Thomas P. Johnston & Amirhossein Sahebkar. (2022) Lipid-based nanoparticulate delivery systems for HER2-positive breast cancer immunotherapy. Life Sciences 291, pages 120294.
Crossref
Nastaran Barati, Amin Reza Nikpoor, Fatemeh Mosaffa, Atefeh Razazan, Ali Badiee, Seyed Mousa Motavallihaghi, Javad Behravan & Mahmoud Reza Jaafari. (2022) AE36 HER2/neu-derived peptide linked to positively charged liposomes with CpG-ODN as an effective therapeutic and prophylactic vaccine for breast cancer. Journal of Drug Delivery Science and Technology 67, pages 102904.
Crossref
Wensi Liu, Haichao Tang, Luanfeng Li, Xiangyi Wang, Zhaojin Yu & Jianping Li. (2021) Peptide‐based therapeutic cancer vaccine: Current trends in clinical application. Cell Proliferation 54:5.
Crossref
Mohammad Z Ahmad, Javed Ahmad, Mohammed Y Alasmary, Basel A Abdel-Wahab, Musarrat H Warsi, Anzarul Haque & Pramila Chaubey. (2021) Emerging advances in cationic liposomal cancer nanovaccines: opportunities and challenges. Immunotherapy 13:6, pages 491-507.
Crossref
Nastaran Hashemzadeh, Mitra Dolatkhah, Khosro Adibkia, Ayuob Aghanejad, Mohammad Barzegar-Jalali, Yadollah Omidi & Jaleh Barar. (2021) Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines. Life Sciences 271, pages 119110.
Crossref
Mahdi Dehghan-Manshadi, Amin Reza Nikpoor, Hossein Hadinedoushan, Fateme Zare, Mojtaba Sankian, Farzaneh Fesahat & Houshang Rafatpanah. (2021) Protective immune response against P32 oncogenic peptide-pulsed PBMCs in mouse models of breast cancer. International Immunopharmacology 93, pages 107414.
Crossref
Maria Aurora Grimaudo. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy 303 315 .
Xiaofeng Dai, Lihui Yu, Xijiang Zhao & Kostya (Ken) Ostrikov. (2020) Nanomaterials for oncotherapies targeting the hallmarks of cancer. Nanotechnology 31:39, pages 392001.
Crossref
Parvin Zamani, Jamshid Gholizadeh Navashenaq, Manouchehr Teymouri, Maryam Karimi, Mohammad Mashreghi & Mahmoud Reza Jaafari. (2020) Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. Life Sciences 252, pages 117646.
Crossref
Atefeh Razazan & Javad Behravan. (2019) Single peptides and combination modalities for triple negative breast cancer. Journal of Cellular Physiology 235:5, pages 4089-4108.
Crossref
Parvin Zamani, Manouchehr Teymouri, Amin Reza Nikpoor, Jamshid Gholizadeh Navashenaq, Zahra Gholizadeh, Shahrzad Amiri Darban & Mahmoud Reza Jaafari. (2020) Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer. European Journal of Cancer 129, pages 80-96.
Crossref
Atefeh Arab, Rezvan Yazdian-Robati & Javad Behravan. (2020) HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development. Archivum Immunologiae et Therapiae Experimentalis 68:1.
Crossref
Javad Behravan, Atefeh Razazan & Ghazal Behravan. (2019) Towards Breast Cancer Vaccines, Progress and Challenges. Current Drug Discovery Technologies 16:3, pages 251-258.
Crossref
Amin Reza Nikpoor, Mahmoud Reza Jaafari, Parvin Zamani, Manouchehr Teymouri, Hamed Gouklani, Ehsan Saburi, Shahrzad Amiri Darban, Ali Badiee, Ali Bahramifar, Mahdi Fasihi-Ramandi & Ramezan Ali Taheri. (2019) Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study. International Journal of Pharmaceutics 567, pages 118492.
Crossref
Nadezhda Knauer, Ekaterina Pashkina & Evgeny Apartsin. (2019) Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins. Pharmaceutics 11:2, pages 91.
Crossref
Sergio Rosales-Mendoza & Omar González-OrtegaSergio Rosales-Mendoza & Omar González-Ortega. 2019. Nanovaccines. Nanovaccines 233 265 .
Yu Zhao, Yugang Guo & Li Tang. (2018) Engineering cancer vaccines using stimuli-responsive biomaterials. Nano Research 11:10, pages 5355-5371.
Crossref
Adil Allahverdiyev, Gamze TariMelahat BagirovaEmrah Sefik Abamor. (2018) Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer. Journal of Breast Cancer 21:4, pages 343.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.